In 2025, Anthropic will grow from $1 billion to $9 billion in ARR (annual recurring revenue). OpenAI, meanwhile, will go from ...

Accurate classification of wetland vegetation is essential for biodiversity conservation and carbon cycle monitoring. This study developed an adaptive ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

One of the most detailed 3D maps of how the human chromosomes are organized and folded within a cell's nucleus is published ...

AI maps fleeting DNA quadruplexes, revealing paired structures that control genes in healthy cells and cancer.

MIT researchers have developed a new method for designing 3D structures that can be transformed from a flat configuration ...

Pinecone recently announced the public preview of Dedicated Read Nodes (DRN), a new capacity mode for its vector database ...

Artificial Intelligence (AI) has achieved remarkable successes in recent years. It can defeat human champions in games like Go, predict protein structures with high accuracy, and perform complex tasks ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...